- Report
- May 2025
- 178 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- May 2025
- 100 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- April 2025
- 120 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- April 2025
- 120 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- March 2025
- 150 Pages
Global
From €5195EUR$5,950USD£4,498GBP
- Report
- May 2025
- 200 Pages
Global
From €2174EUR$2,490USD£1,882GBP
- Report
- January 2026
- 184 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 186 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 180 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 199 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 193 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 190 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 195 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 187 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 197 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 194 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 188 Pages
Global
From €3439EUR$3,939USD£2,978GBP
- Report
- January 2026
- 192 Pages
Global
From €3439EUR$3,939USD£2,978GBP

The Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical manufacturing industry. It is composed of companies that provide services to pharmaceutical and biotechnology companies, such as drug development, clinical trial materials, and commercial manufacturing. CDMOs are typically engaged by pharmaceutical companies to outsource the development and manufacturing of their products. This allows the pharmaceutical companies to focus on their core competencies, such as drug discovery and marketing.
CDMOs provide a range of services, including process development, analytical services, formulation development, clinical trial materials, and commercial manufacturing. They also provide regulatory support, such as filing of Investigational New Drug (IND) applications and New Drug Applications (NDAs).
Some of the major players in the CDMO market include Lonza, Patheon, Boehringer Ingelheim, Catalent, and Ajinomoto. Other companies in the market include Recipharm, Jubilant, Vetter, and Fareva. Show Less Read more